Loading...
01/11 10:31
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlights strong financial metrics with high margins, a positive revenue outlook, and optimism in future demand, especially in medical and AI sectors. New product introductions and high isolation voltage devices are well-received. Despite increased expenses and a decrease in fiscal year revenue, the company's strategic R&D investments and strong profitability metrics suggest positive sentiment. The Q&A section indicates confidence in new business and product expansion. The quarterly dividend and lack of negative guidance further support a positive outlook, projecting a stock price increase of 2% to 8%.
Revenue $3.89 million (up 3% year-over-year); driven by a $270,000 or 558% increase in contract R&D revenue, partially offset by a 1% decrease in product sales.
Gross Margin 79% (up from 76% year-over-year); due to a more profitable product mix and a larger portion of direct rather than distributor sales.
Total Expenses Increased 17% year-over-year; due to a 28% increase in R&D expenses, partially offset by a 2% decrease in SG&A.
Net Income $3.89 million (up 2% year-over-year); primarily due to increased revenue and higher margins, partially offset by increased expenses.
Operating Margin 58%; strong profitability metrics.
Pre-tax Margin 65%; strong profitability metrics.
Net Margin 54%; strong profitability metrics.
Fiscal Year Revenue Decreased 13% year-over-year; due to decreases in the first three quarters of the fiscal year, partially offset by an increase in the most recent quarter.
Fiscal Year Gross Margin 84% (up from 77% year-over-year); due to a more profitable product mix and a larger portion of direct rather than distributor sales.
Fiscal Year Total Expenses Increased 25% year-over-year; due to a 33% increase in R&D and a 13% increase in SG&A, primarily due to increased new product development and increased sales and marketing.
Net Income for Fiscal Year $15.1 million (down 12% year-over-year); in a tough industry environment, but still a solid $3.12 per share.
Comprehensive Income $15.8 million; includes approximately $700,000 in unrealized gains on marketable securities.
Operating Margin for Fiscal Year 62%; strong profitability metrics.
Pre-tax Margin for Fiscal Year 70%; strong profitability metrics.
Net Margin for Fiscal Year 58%; strong profitability metrics.
Fixed Asset Purchases $1.2 million last fiscal year; planning $2 million to $3 million in capital investments for fiscal 2026.
Accounts Receivable Increased $444,000 during fiscal 2025; due to increased revenue in the fourth quarter and the timing of customer payments.
Inventories Increased $291,000 in a year; working process inventories increased by $968,000, providing flexibility to make different products depending on market demand.
Dividends Paid $1 per share quarterly dividend; over $200 million paid in dividends since inception.
New Product Launches: Launched the world's most advanced magnetic switch sensors, high sensitivity ultra miniature sensor, high sensitivity rotation sensor, first wafer level chip scale sensors, and advanced position sensors.
R&D Investment: Invested 14% of revenue in R&D, focusing on next-generation MRAM for anti-tamper applications, next-generation sensors for hearing aids and medical devices, and extremely sensitive TMR sensors.
Market Expansion: Executed an extension of the supplier partnering agreement with Abbott Laboratories, a leading supplier of implantable medical devices.
Trade Shows Participation: Exhibiting at two major trade shows: Sensor Plus in Nuremberg, Germany, and Sensor Converge in Silicon Valley.
Manufacturing Capacity Expansion: Completed planned expansion including construction work and infrastructure upgrades to support new equipment.
New Equipment Deployment: Deployed one new machine in the past fiscal year and another this quarter, with a several million dollar machine scheduled to arrive next quarter.
Strategic Focus on R&D: Significantly increased investment in R&D to drive future growth.
Tariff Management Strategy: Identified risks related to tariffs but positioned well due to in-house fabrication and ample inventories.
Tariffs and Trade Barriers: Risks related to tariffs include potential global recession or industry downturn, tariffs on imported raw materials, and retaliatory tariffs on exported parts. While the company has been paying 25% tariffs on raw materials from China since 2018, it has not significantly impacted costs due to in-house fabrication and exemptions for semiconductors.
Economic Environment: Uncertainties related to the economic environments and the industries served pose risks to future sales and revenue.
Supply Chain Challenges: The company has ample raw material and work-in-process inventories, which provide a buffer against supply disruptions, including those caused by tariffs.
Regulatory Issues: Potential regulatory changes could impact tariffs and trade barriers, affecting the company's operations and costs.
Competitive Pressures: The company believes its unique tariff situation and inventory levels could provide competitive advantages compared to U.S.-based companies with higher tariff exposure.
R&D Investment: Increased investment in R&D, spending 14% of revenue in the past year, with a focus on new product development.
New Product Launches: Launched several new products including advanced magnetic switch sensors and wafer level chip scale sensors.
Manufacturing Expansion: Completed planned expansion and upgrades to support new equipment, with a significant machine scheduled to arrive next quarter.
Supplier Agreement: Executed an extension of the supplier partnering agreement with Abbott Laboratories.
Trade Shows Participation: Exhibiting at major trade shows to showcase new products and drive future sales.
Revenue Growth: Expectations for future revenue growth driven by new product launches and increased R&D investment.
Capital Expenditures: Planning $2 million to $3 million in capital investments for fiscal 2026, primarily for wafer fabrication equipment.
Profitability Outlook: Investments in R&D and new products expected to pay off with higher revenues in the future.
Dividends: Continued payment of dividends, with over $200 million paid since inception.
Quarterly Dividend: $1 per share quarterly dividend paid in the past quarter and another dividend declared to be paid at the end of this month.
Total Dividends Paid: Over $200 million, more than $42 per share in dividends paid since the start of the dividend program 10 years ago.
Share Repurchase Program: None
The earnings call shows promising signs of future growth with strong R&D results and expansion plans, especially in core markets. The company's focus on innovative products like wafer-level chip scale sensors and advanced magnetic switch sensors is expected to drive sales. While some responses were vague, the overall sentiment from the Q&A indicates optimism, particularly with upcoming growth drivers and industry recovery. The anticipation of significant cash flow savings and a strong pipeline further supports a positive outlook for stock price movement.
The earnings call highlights strong financial performance with comprehensive income and positive operating cash flow, despite lower margins. The Q&A reveals growth expectations in the PUF business and potential in replacing rare earth metals. Strategic investments in wafer-scale packaging and patents on SOT RAM are promising. Although management was vague on certain reporting aspects, the overall sentiment is positive with anticipated growth in military orders and new market expansions, supporting a positive stock price movement.
The earnings call highlights strong financial metrics with high margins, a positive revenue outlook, and optimism in future demand, especially in medical and AI sectors. New product introductions and high isolation voltage devices are well-received. Despite increased expenses and a decrease in fiscal year revenue, the company's strategic R&D investments and strong profitability metrics suggest positive sentiment. The Q&A section indicates confidence in new business and product expansion. The quarterly dividend and lack of negative guidance further support a positive outlook, projecting a stock price increase of 2% to 8%.
The earnings call reveals significant challenges: a 25% revenue drop, increased expenses, and economic uncertainties. Despite a gross margin improvement and optimistic market demand outlook, the absence of a share repurchase program and concerns over inventory management, competitive pressures, and regulatory issues weigh heavily. The Q&A section highlights inventory gluts and vague responses on critical business areas, further dampening sentiment. These factors, coupled with decreased net income and increased expenses, suggest a negative stock price movement in the short term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
